Results 151 to 160 of about 11,066 (200)

Clinical utility analysis of the Hoxb8 mast cell activation test for the diagnosis of peanut allergy. [PDF]

Allergy
Bachmeier-Zbären N, Celik A, van Brummelen R, Roos N, Steinmann M, Hoang JA, Yin X, Ditlof CM, Duan L, Upton JEM, Kaufmann T, Eggel A, Eiwegger T, MONAS working group.   +13 more
europepmc   +1 more source

Oral Food Challenge in Children with Tree Nut and Peanut Allergy: The Predictive Value of Diagnostic Tests. [PDF]

Diagnostics (Basel)
Cela L, Gravina A, Semeraro A, Pastore F, Morelli R, Marchetti L, Brindisi G, Olivero F, Piccioni MG, Zicari AM, Anania C.   +10 more
europepmc   +1 more source

Whole Blood Transcriptomics Identifies Differences in Innate Immune Pathway Expression in Infants at Risk for Peanut Allergy. [PDF]

Clin Exp Allergy
Lang A, Gadd S, Gunderman L, Lippner E, Devonshire A, Schipma MJ, Berdnikovs S, Kumar R.   +7 more
europepmc   +1 more source

Design of the Intervention to Reduce Early Peanut Allergy in Children (iREACH): A practice-based clinical trial. [PDF]

Pediatr Allergy Immunol
Bilaver LA, Ariza AJ, Binns HJ, Jiang J, Cohn R, Sansweet S, Hultquist H, Panza JL, Togias A, Gupta RS.   +9 more
europepmc   +1 more source

Risk subgroups and intervention effects among infants at high risk for peanut allergy: A model for clinical decision making. [PDF]

Clin Exp Allergy
Li Y, Devonshire A, Huang B, Andorf S.
europepmc   +1 more source

Development of an innovative curriculum for paediatricians on peanut allergy prevention: How do we address current guidelines? [PDF]

Clin Teach
Leeds S, Slade M, Hafler J, Samady W, Jiang J, Bilaver L, Gupta RS.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Treatment of Peanut Allergy

Pediatrics In Review, 2021
1. Amy Burris, MD*,† 2. Theresa Bingemann, MD*,† 1. *Department of Medicine: Allergy, Immunology, and Rheumatology and 2. †Division of Pediatric Allergy and Immunology, University of Rochester Medical Center, Rochester, NY Peanut allergy (PA) affects 0.5% to 2% of children and is often a persistent condition that poses the risk of life ...
Amy, Burris, Theresa, Bingemann
openaire   +2 more sources

Peanut allergy

Current Opinion in Pediatrics, 2010
To highlight recent advances in management of peanut allergy.Peanut allergy presents during early childhood. The prevalence of peanut allergy in children in developed countries appears to be increasing. Several factors, such as peanut-specific or environmental, are hypothesized as contributing to increased prevalence.
Milind, Pansare, Deepak, Kamat
openaire   +2 more sources

Palacos and peanut allergy

Hip International, 2004
Palacos cement contains peanut oil. The manufacturer's instruction states that its use is contraindicated in patients allergic to peanuts. Awareness of this fact by orthopaedic surgeons was evaluated by postal questionnaire, which showed that 73% of those responding were not aware.
M, Ganapathi, M W, Jones, R S H, Pumphrey   +2 more
openaire   +2 more sources

Peanut Allergy

Pediatric Clinics of North America, 2011
Peanut allergy may affect up to 2% of children in some countries, making it one of the most common conditions of childhood. Peanut allergy is a marker of a broad and possibly severe atopic phenotype. Nearly all children with peanut allergy have other allergic conditions. Peanut accounts for a disproportionate number of fatal and near fatal food-related
openaire   +3 more sources